ATE493497T1 - Verfahren zur herstellung von oligopeptiden - Google Patents
Verfahren zur herstellung von oligopeptidenInfo
- Publication number
- ATE493497T1 ATE493497T1 AT07733646T AT07733646T ATE493497T1 AT E493497 T1 ATE493497 T1 AT E493497T1 AT 07733646 T AT07733646 T AT 07733646T AT 07733646 T AT07733646 T AT 07733646T AT E493497 T1 ATE493497 T1 AT E493497T1
- Authority
- AT
- Austria
- Prior art keywords
- oligopeptides
- nucleic acid
- acid sequence
- fusion protein
- synthesizing
- Prior art date
Links
- 102000015636 Oligopeptides Human genes 0.000 title abstract 4
- 108010038807 Oligopeptides Proteins 0.000 title abstract 4
- 238000004519 manufacturing process Methods 0.000 title 1
- 108020001507 fusion proteins Proteins 0.000 abstract 3
- 102000037865 fusion proteins Human genes 0.000 abstract 3
- 150000007523 nucleic acids Chemical class 0.000 abstract 3
- 108091005804 Peptidases Proteins 0.000 abstract 2
- 239000004365 Protease Substances 0.000 abstract 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 abstract 2
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 2
- 238000003776 cleavage reaction Methods 0.000 abstract 2
- 238000000338 in vitro Methods 0.000 abstract 2
- 108020004707 nucleic acids Proteins 0.000 abstract 2
- 102000039446 nucleic acids Human genes 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 230000007017 scission Effects 0.000 abstract 2
- 230000002194 synthesizing effect Effects 0.000 abstract 2
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 208000036142 Viral infection Diseases 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 239000013604 expression vector Substances 0.000 abstract 1
- 238000003306 harvesting Methods 0.000 abstract 1
- 238000013507 mapping Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/50—Fusion polypeptide containing protease site
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
- C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Plant Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0608368.7A GB0608368D0 (en) | 2006-04-28 | 2006-04-28 | Process for making Oligopeptides |
| PCT/GB2007/050225 WO2007125371A2 (en) | 2006-04-28 | 2007-04-30 | Process for making oligopeptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE493497T1 true ATE493497T1 (de) | 2011-01-15 |
Family
ID=36589936
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT07733646T ATE493497T1 (de) | 2006-04-28 | 2007-04-30 | Verfahren zur herstellung von oligopeptiden |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9382546B2 (de) |
| EP (1) | EP2041286B1 (de) |
| CN (1) | CN101512000B (de) |
| AT (1) | ATE493497T1 (de) |
| DE (1) | DE602007011616D1 (de) |
| GB (1) | GB0608368D0 (de) |
| WO (1) | WO2007125371A2 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2402023A1 (de) | 2006-06-28 | 2012-01-04 | Statens Serum Institut | Ausweitung des T-Zell-Repertoires zum Einbeziehen subdominanter Epitope durch Impfung mit als Proteinfragmente oder Peptid-Cocktails abgegebenen Antigenen |
| EP2620446A1 (de) | 2012-01-27 | 2013-07-31 | Laboratorios Del Dr. Esteve, S.A. | Immunogene zur HIV-Impfung |
| CN105753989A (zh) * | 2014-12-15 | 2016-07-13 | 牛津疫苗医学生物科技（英国）有限公司 | 人工多抗原融合蛋白及其制备和应用 |
| AU2020384323A1 (en) | 2019-11-14 | 2022-06-02 | Aelix Therapeutics, S.L. | Dosage regimens for vaccines |
| GB202017119D0 (en) | 2020-10-28 | 2020-12-09 | Oxford Vacmedix Uk Ltd | Polypeptides for cancer treatment |
| GB202017118D0 (en) | 2020-10-28 | 2020-12-09 | Oxford Vacmedix Uk Ltd | Coronavirus polypeptide |
| GB202019767D0 (en) | 2020-12-15 | 2021-01-27 | Chain Biotechnology Ltd | Compostitions and methods |
| CN117957017A (zh) | 2021-05-11 | 2024-04-30 | 牛津疫苗医学公司 | 包含重组重叠肽和天然蛋白质的疫苗制剂 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5795974A (en) * | 1993-12-10 | 1998-08-18 | University Of Utah Research Foundation | Mycoplasma arthritidis superantigen |
| CN1193998A (zh) | 1995-04-11 | 1998-09-23 | 麦克公司 | 以二肽基础的化合物生产的生物方法 |
| SE9903031D0 (sv) * | 1999-08-27 | 1999-08-27 | Eurodiagnostica Ab | Peptide mixture and vaccine against a chronic viral infection |
| CA2450548C (en) * | 2001-06-15 | 2012-05-01 | F. Hoffmann-La Roche Ag | Method for the recombinant production of peptidic antiviral fusion inhibitors, and acetylation of gb41 fragments |
| WO2004002415A2 (en) * | 2002-06-27 | 2004-01-08 | Dana-Farber Cancer Institute, Inc. | Compositions and methods for modulating a cytotoxic t lymphocyte immune response |
-
2006
- 2006-04-28 GB GBGB0608368.7A patent/GB0608368D0/en not_active Ceased
-
2007
- 2007-04-30 DE DE602007011616T patent/DE602007011616D1/de active Active
- 2007-04-30 WO PCT/GB2007/050225 patent/WO2007125371A2/en not_active Ceased
- 2007-04-30 CN CN200780024534.6A patent/CN101512000B/zh active Active
- 2007-04-30 US US12/298,835 patent/US9382546B2/en active Active
- 2007-04-30 AT AT07733646T patent/ATE493497T1/de not_active IP Right Cessation
- 2007-04-30 EP EP07733646A patent/EP2041286B1/de active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2041286A2 (de) | 2009-04-01 |
| WO2007125371A2 (en) | 2007-11-08 |
| GB0608368D0 (en) | 2006-06-07 |
| EP2041286B1 (de) | 2010-12-29 |
| US20100291061A1 (en) | 2010-11-18 |
| CN101512000A (zh) | 2009-08-19 |
| DE602007011616D1 (de) | 2011-02-10 |
| US9382546B2 (en) | 2016-07-05 |
| WO2007125371A3 (en) | 2008-03-13 |
| CN101512000B (zh) | 2016-08-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE493497T1 (de) | Verfahren zur herstellung von oligopeptiden | |
| DE60310562D1 (de) | Verfahren zur verstärkung einer immunantwort von nukleinsäureimpfungen | |
| MX358725B (es) | Antigenos prostaticos de consenso, molecula de acido nucleico que los codifica y vacuna y usos que los comprenden. | |
| PE20110310A1 (es) | Axmi-115, axmi-113, axmi-005, axmi-163 y axmi-184: proteinas insecticidas | |
| DE60311731D1 (de) | Verfahren zur rekombinanten Herstellung von Antifusogenikpeptide | |
| EP2865387A3 (de) | Priming einer Immunantwort | |
| MX2019004648A (es) | Peptidos escindibles y proteinas insecticidas y nematicidas que los comprenden. | |
| CY1109715T1 (el) | IL-1β ΔΕΣΜΕΥΤΙΚΑ ΑΝΤΙΣΩΜΑΤΑ ΚΑΙ ΘΡΑΥΣΜΑΤΑ ΑΥΤΩΝ | |
| EP2395091A3 (de) | Pflanzen mit verbesserten Ertragseigenschaften und Verfahren zu deren Herstellung | |
| WO2007064917A3 (en) | Methods of preparation of recombinant forms of human beta-amyloid protein and uses of these proteins | |
| EP2468881A3 (de) | Mehrfache Genexpression mit sORF-Konstrukten und Verfahren mit Polyproteinen, Pro-Proteinen und Proteolyse | |
| ES2531372T3 (es) | Enzimas de procesamiento fusionadas a marcadores de proteínas básicas | |
| JP2007516696A5 (de) | ||
| WO2006119516A3 (en) | Expression of viral proteins in plants | |
| WO2006090385A3 (en) | Protease inhibitors and method of screening thereof | |
| WO2010132341A3 (en) | Production of recombinant proteins utilizing non-antibiotic selection methods and the incorporation of non-natural amino acids therein | |
| ES2531115T3 (es) | Combinaciones de clados de RrgB neumocócicos | |
| NZ596501A (en) | Casb7439 constructs | |
| ATE533851T1 (de) | Prozess zur herstellung eines plastidgerichteten proteins in pflanzenzellen | |
| TW201008576A (en) | New fusion proteins and their use for the preparation of vaccines against hepatitis C | |
| DE60236579D1 (de) | Bakteriophagenvermittelte impfung | |
| ATE374825T1 (de) | Verwendung von caspasen zur herstellung von reifen rekombinanten fusionsproteinen | |
| DE602005017034D1 (de) | Signalpeptid zur herstellung eines polypeptids | |
| WO2006086607A3 (en) | Novel proteins with enhanced functionality and methods of making novel proteins using circular permutation | |
| DK1334197T3 (da) | Gær-afledt vaccine mod IPNV |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |